CA 27.29, serum

Applies To: Cancer Antigen 27.29 (CA 27.29) is an vitro diagnostic test for the quantitative serial determination in human serum. The test is intended for use as an aid in monitoring patients previously treated for Stage II or Stage III breast cancer.

Test Includes:

Request Form: Special Chemistry Form 2

Collection: Routine venipuncture

Storage Instructions: Centrifuge, store serum at 2-8º C and deliver to lab within 24 hours. If delayed more than 24 hours, freeze serum.

Causes for Rejection: Hemolysis

Availability: Samples are received 24 hours per day.

Turnaround Time: STAT 1 hour, Routine 4 Hours

Special Instructions: N/A

Specimen: Blood or serum

Volume: 7mL blood

Minimum Volume: 0.4 mL serum

Container: SST/gel barrier tube or plain red-stopped tube

Reference Range: 0.0-38.6 U/mL

Therapeutic Range:

Critical Values:

Test Methodology: Chemiluminescence

Interfering Substances: Heterophilic antibodies in human serum can react with reagent I immunoglobulins interfering with in vitro immunoassays. Patient routinely exposed to animals or to animal serum products can be prone to this interference and anomalous values may be observed.

Reviewed: April 2008 by D. Davis, MT(ASCP)

A B C D E F G H I J K L M N O P Q R S T U V W-Z

Anatomic Path Procedures LSG Home